Domača stranSBMFF • OTCMKTS
add
Sino Biopharmaceutical Ltd
Prejšnji trg. dan.
0,41 $
Letni razpon
0,31 $ - 0,47 $
Tržna kapitalizacija
53,96 mrd. HKD
Povprečni obseg
364,00
Razm. P/E
-
Dividendna donosnost
-
Primarna borza
HKG
Borzne novice
Financial Times
pred 28 minutami
Investors pour billions into S&P equal weight fund as tech fears rise
0,97 %
0,78 %
0,11 %
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (CNY) | jun. 2024info | Sprememba L/L |
|---|---|---|
Prihodek | 7,94 mrd. | 11,14 % |
Stroški poslovanja | 4,78 mrd. | 10,58 % |
Čisti dohodek | 1,51 mrd. | 139,69 % |
Čista dobičkovnost prihodkov | 19,01 | 115,78 % |
Earnings per share | — | — |
EBITDA | 1,98 mrd. | 8,88 % |
Efektivna davčna stopnja | 16,99 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (CNY) | jun. 2024info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 13,18 mrd. | −15,93 % |
Skupna sredstva | 66,70 mrd. | 1,62 % |
Skupne obveznosti | 24,58 mrd. | −15,76 % |
Celoten lastniški kapital | 42,12 mrd. | — |
Shares outstanding | 18,21 mrd. | — |
Razmerje P/B | 0,23 | — |
Donosnost sredstev | 6,50 % | — |
Donosnost kapitala | 8,37 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (CNY) | jun. 2024info | Sprememba L/L |
|---|---|---|
Čisti dohodek | 1,51 mrd. | 139,69 % |
Denar iz dejavnosti | 1,54 mrd. | 15,25 % |
Denar iz naložb | −1,02 mrd. | 49,91 % |
Denar iz financiranja | −2,05 mrd. | −1,42 % |
Neto sprememba denarnih sredstev | −1,52 mrd. | 43,37 % |
Prost denarni tok | 1,09 mrd. | 36,59 % |
Vizitka
Sino Biopharmaceutical Limited, shortly Sino Biopharm, is a pharmaceutical conglomerate in China. The Company was listed on the Hong Kong Stock Exchange in 2000 and included in 2013 as a constituent stock of MSCI Global Standard Indices – MSCI China Index, Hang Seng Index in 2018, Hang Seng China Enterprises Index in 2019, and Hang Seng Connect Biotech 50 Index and Hang Seng China 25 Index in 2020.
The Group’s principal subsidiaries include: Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Beijing Tide Pharmaceutical Co. Ltd., Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd., Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd., Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd. and invoX Pharma Limited. Its products including biopharmaceutical and chemical medicines are used in a host of therapeutic areas, such as tumors, liver diseases, respiratory system diseases and surgery/analgesia. Wikipedia
Generalni direktor
Datum ustanovitve
2000
Spletno mesto
Zaposleni
24.437
